American Nurse Journal (ANJ)Youth Vaping Detection in Primary Care

⚠️ Small Study Evidence

A Midwest primary care pilot using the CRAFFT 2.1+N self-administered screening tool raised vaping documentation rates from 45% to 75% in patients ages 12 to 21. Among screened patients, 6.1% reported current or former vaping, mirroring CDC national data.

Key Clinical Considerations

• Adolescents often under-report vaping due to fears about confidentiality, parental disclosure, and legal consequences for those under 21
• Standard tobacco questions miss vaping because teens don’t always connect e-cigarettes to “tobacco”; vaping-specific terminology is required
• Nicotine exposure during adolescence impairs the developing prefrontal cortex, which governs judgment and impulse control until age 25
• Provider knowledge and comfort showed descriptive but not statistically significant improvement (n=8 providers), limiting conclusions about education impact
• EVALI and unknown long-term pulmonary effects make early detection a patient safety priority, not just a behavioral one

Practice Applications

• Hand every patient ages 12 to 21 a self-administered CRAFFT 2.1+N at check-in, not just those who “look at risk”
• Document vaping status as a distinct field in the EHR, separate from tobacco
• Reassure adolescents about confidentiality before screening, and conduct it without parents in the room
• Refer positive screens for brief intervention using the AAP Act-Counsel-Treat model